Labshake search
Citations for Peprotech :
2151 - 2200 of 2315 citations for 6 METHYL 4 4 NITRO PHENYL 2 OXO 1 2 3 4 TETRAHYDRO PYRIMIDINE 5 CARBOXYLIC ACID ETHYL ESTER since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... 40 ng/ml IGF-1 (all supplements from Peprotech, London, United Kingdom). Medium with all supplements is called Expansion Medium.
-
bioRxiv - Cancer Biology 2023Quote: ... TF-1 cells were supplemented with GM-CSF 10 ng/ml (Peprotech). AS-E2 cells were cultured in Iscove’s Modified Dulbecco’s Media (IMDM ...
-
bioRxiv - Cell Biology 2024Quote: ... 1 ng/ mL transforming growth factor type β3 (TGFβ3, Peprotech #100-36E), 10 μM DAPT (Axon Medchem #Axon1484) ...
-
bioRxiv - Genomics 2020Quote: ... and treated for 16h with 1 ng/mL recombinant human Interferon gamma (Peprotech). After 16h ...
-
bioRxiv - Bioengineering 2020Quote: ... and 1 ng/ml recombinant human fibroblast growth factor-basic (bFGF, Peprotech, UK). The selection of MSCs was based on plastic adherence and the cells were stored in liquid nitrogen at passage 3 until further use ...
-
bioRxiv - Bioengineering 2021Quote: ... 100 ng mL−1 of recombinant human GDF-15 (120-28C; PeproTech®), and 2 µM of A83-01 (9001799 ...
-
CAP1 and cofilin1 cooperate in neuronal actin dynamics, growth cone function and neuron connectivitybioRxiv - Neuroscience 2020Quote: Neurons were cultured for 1 d before incubation with 100 µM BDNF (PeproTech), 1 µg/µl Ephrin A5 (R&D System) ...
-
bioRxiv - Cancer Biology 2019Quote: ... on a reservoir containing 10% FBS and 10 ng mL−1 TFGβ (Peprotech). After 48 h the cells on the lower chamber were fixed in 4% PFA for 15 min ...
-
bioRxiv - Cell Biology 2020Quote: ... and transforming growth factor beta 1 (TGFβ1) (50ng/ml; Peprotech, New Jersey, USA). For osteogenic differentiation ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 20% FCS and 2.5 ng x ml−1 GM-CSF (Peprotech). After 5-7 days ...
-
bioRxiv - Plant Biology 2019Quote: ... with either 50 ng·ml−1 recombinant hVEGF-165 (Peprotech, Rocky Hill, NJ, USA) or concentrated protein supernatants obtained from cultures of the genetically modified or recipient (UVM4/UVM11 ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 20% FCS and 2.5 ng x ml-1 GM-CSF (Peprotech). After 5-7 days ...
-
bioRxiv - Immunology 2020Quote: ... or 5ng/mL of IL-1 β (both from PeproTech, ListerFish, Milan, Italy), or 10% of pooled EM-PF ...
-
bioRxiv - Cancer Biology 2020Quote: ... 1% Insulin Transferin Selenium (Thermo, 41400045) and 10ng/ml FGF2 (Peprotech, 100-18B). Following cell outgrowth and expansion ...
-
bioRxiv - Neuroscience 2020Quote: ... the membrane was incubated with anti-mCSF1 antibody (1:1000, PeproTech, 500-P62G) at 4°C overnight ...
-
bioRxiv - Immunology 2021Quote: ... #AV-7016-1) and recombinant murine IFNγ (20 ng/m(PEPROTECH, #315-05)) or towards an alternative activation phenotype (M(Il-4) ...
-
bioRxiv - Immunology 2022Quote: ... 100 μg CpG-ODN (Integrated DNA Technologies) and 1 μg GM-CSF (Peprotech). The animals were then challenged 10 days later ...
-
bioRxiv - Neuroscience 2022Quote: ... and 30 ng ml−1 platelet-derived growth factor (PDGF) (Peprotech, 100-13A)] and 60μg ml−1 N-Acetyl cysteine (Sigma ...
-
bioRxiv - Developmental Biology 2022Quote: ... NM was supplemented with the growth factors BDNF (20 ng ml−1, Peprotech) and NT3 (20ng ml−1 ...
-
Neuroprotective Effects of VEGF-B in a Murine Model of Aggressive Neuronal Loss With Childhood OnsetbioRxiv - Neuroscience 2023Quote: For pharmacological treatment we used rhIGF-1 (Cat: 100-11, Peprotech, NJ, USA) and rhVEGF-B (Cat ...
-
bioRxiv - Systems Biology 2023Quote: ... or 100 ng/ml of recombinant human interleukin 1 beta (IL-1β, PeproTech).
-
bioRxiv - Bioengineering 2023Quote: ... followed by the addition of 10 ng mL−1 FGF9 (100-23, Peprotech) and incubation for seven days ...
-
bioRxiv - Cell Biology 2023Quote: ... with or without 50 ng/ml of recombinant human R-Spondin-1 (PeproTech). For Wnt5a-induced actin cytoskeleton rearrangements ...
-
bioRxiv - Immunology 2023Quote: ... The chemotaxis medium with or without CXCL13 (1 μg/ml; PeproTech #250-24) or CXCL12/SDF-1α (100 ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... 1% penicillin/streptomycin and 10ng/mL M-CSF (Peprotech, 315-02; Cranbury, NJ). Cells were seeded in chamber slides (Thermo Fisher ...
-
bioRxiv - Molecular Biology 2023Quote: ... supplemented with 100 ng ml−1 M-CSF (Peprotech, 300-25; London, UK), 25 ng/mL IL-3 (PHC0031) ...
-
bioRxiv - Neuroscience 2024Quote: ... brain-derived neurotrophic factor (BDNF, 1:1000, 10 ng/mL, Peprotech, 450-02) recombinant proteins ...
-
bioRxiv - Neuroscience 2024Quote: ... glial-derived neurotrophic factor (GDNF, 10 ng/mL, 1:1000, Peprotech, 450-10), brain-derived neurotrophic factor (BDNF ...
-
bioRxiv - Immunology 2024Quote: ... activated OT-1 T cells were expanded in IL-15 (20ng/ml; Peprotech).
-
bioRxiv - Bioengineering 2022Quote: ... and 1 ng/mL basic fibroblastic growth factor (bFGF, 100-18B, PeproTech, London, UK) at 37 °C and 5% CO2 ...
-
bioRxiv - Immunology 2022Quote: ... and 1 ng/mL basic fibroblastic growth factor (bFGF, 100-18B, PeproTech, London, UK) at 37 ºC and 5% CO2 ...
-
bioRxiv - Bioengineering 2022Quote: ... and 1 ng/ml basic fibroblast growth factor (bFGF, 100-18B, PeproTech, London, UK) at 37 ºC and 5% CO2 ...
-
bioRxiv - Bioengineering 2022Quote: ... and 1 ng/mL basic fibroblastic growth factor (bFGF, 100-18B, PeproTech, London, UK) at 37 °C and 5% CO2 ...
-
bioRxiv - Genomics 2022Quote: ... 1% Pen-Strep) supplemented with final 50 ng/ml KGF (Peprotech, 100-19-1MG) for 48 h ...
-
bioRxiv - Genomics 2022Quote: ... 1% Pen-Strep) supplemented with final 50 ng/ml KGF (Peprotech, 100-19-1MG), 200 nM LDN193189 (Sigma Aldrich ...
-
bioRxiv - Bioengineering 2022Quote: ... and 1 ng/ml basic fibroblast growth factor (bFGF, 100-18B, PeproTech, London, UK) at 37 °C and 5% CO2 ...
-
bioRxiv - Bioengineering 2022Quote: ... and 1 ng/mL basic fibroblastic growth factor (bFGF, 100-18B, PeproTech, London, UK) at 37 ºC and 5% CO2 ...
-
bioRxiv - Bioengineering 2023Quote: ... and 1 ng/mL basic fibroblastic growth factor (bFGF, 100-18B, PeproTech, London, UK) at 37°C and 5% CO2 ...
-
bioRxiv - Neuroscience 2023Quote: ... and recombinant Human/Murine/Rat Activin A (50 ng ml−1; PeproTech, 120-14P). From day 12 ...
-
bioRxiv - Biochemistry 2022Quote: ... anti-BMP-7 GF (#500-P198 B, Peprotech, Cranbury, NJ, USA, WB: 1:2000), anti-collagen I (#ab34710 ...
-
bioRxiv - Immunology 2023Quote: ... 1 ml of media supplemented with 20 ng/ml recombinant human GM-CSF (Peprotech) was added to each well ...
-
bioRxiv - Molecular Biology 2020Quote: ... 1 mL of base medium supplied with 12 μg/mL Recombinant Human FGF-basic (PEPROTECH) and KnockOutTM Serum Replacement (1:100 ...
-
bioRxiv - Microbiology 2020Quote: Dividing THP-1 cells were treated with 10 ng/mL recombinant human IL-1β (Peprotech) for the times indicated ...
-
bioRxiv - Molecular Biology 2019Quote: ... but supplemented with 100 ng ml−1 human recombinant noggin (Peprotech, cat. no. 120-10C) and 20% R-spondin conditioned medium (Sigma ...
-
bioRxiv - Immunology 2021Quote: ... PenStrep and macrophage colony-stimulating factor (M-CSF, 0.5 ng ml−1; Peprotech, 300-25) at 37°C ...
-
bioRxiv - Immunology 2020Quote: MT1-MMPf/f or MT1-MMPΔLysM BMDMs were treated with 1 ng/mL LPS (Peprotech) for 24 h to stimulate TGFβ1 production ...
-
bioRxiv - Cancer Biology 2022Quote: ... with 25 ng/mL recombinant murine Macrophage Colony Stimulating Factor (mCSF-1) (Peprotech, 315-02) for 7 days (media changes every 3 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... MCP-1 (cat# 300-04) and IL-8 (cat# 200-08) was purchased from PeproTech and used at a concentration of 10ng/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... 53 [supplemented with 30 ng ml−1 basic fibroblast growth factor (bFGF) (Peprotech, 100-18B) and 30 ng ml−1 platelet-derived growth factor (PDGF ...
-
bioRxiv - Cell Biology 2023Quote: ... endogenous Wnt ligand secretion was inhibited by overnight treatment with 1 μM LGK-974 (PeproTech). Subsequently ...